A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

Clinical trial NCT01279616 · TERMINATED

Trial details

NCT number: NCT01279616
Sponsor: Nationwide Children's Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2010-09-01
Primary completion: 2015-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.